Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma
Clinical trial NCT03311126 · TERMINATED
Trial details
- NCT number
- NCT03311126
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2023-07-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.